Diagnosis of Pre-eclampsia and Eclampsia
Pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) occurring after 20 weeks of gestation combined with either proteinuria (≥300 mg/24h) OR evidence of maternal organ dysfunction, while eclampsia is defined as the occurrence of seizures in a woman with pre-eclampsia. 1, 2, 3
Core Diagnostic Criteria for Pre-eclampsia
Blood Pressure Requirements
- Systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg confirmed on two separate occasions at least 15 minutes apart 2
- For severe hypertension (≥160/110 mmHg), confirmation should occur within 15 minutes 2
- Hypertension must be new-onset after 20 weeks of gestation in previously normotensive women 1, 2, 3
- Blood pressure measurement technique is critical, as errors have been implicated in maternal deaths 1
Proteinuria Assessment
- Significant proteinuria is defined as >0.3 g/24h or albumin-creatinine ratio ≥30 mg/mmol 2
- Dipstick testing ≥1+ should prompt immediate quantitative evaluation using albumin-creatinine ratio or 24-hour urine collection 2
- An albumin-creatinine ratio <30 mg/mmol reliably excludes proteinuria 2
- Proteinuria is present in only 75% of pre-eclampsia cases and is no longer required for diagnosis 2, 3
Alternative Diagnostic Criteria (When Proteinuria Absent)
When proteinuria is absent, pre-eclampsia can be diagnosed if gestational hypertension is accompanied by any one of the following maternal organ dysfunctions 2:
Renal dysfunction:
- Serum creatinine ≥1.1 mg/dL or doubling of baseline creatinine 2
Hepatic dysfunction:
- Elevated liver transaminases ≥2 times upper limit of normal 2, 3
- Persistent epigastric or right upper quadrant pain 3
Hematological dysfunction:
Neurological complications:
- Severe headache unresponsive to medication 1, 2
- Visual disturbances (scotomata, photophobia, blurred vision) 1, 2, 3
- Altered mental status 2
Pulmonary complications:
Uteroplacental dysfunction:
- Fetal growth restriction 2
- Abnormal umbilical artery Doppler waveform analysis 2
- Reduced fetal movements 1
- Intrauterine fetal death 2
Eclampsia Diagnosis
Eclampsia is diagnosed when seizures occur in a woman with pre-eclampsia, typically presenting as generalized tonic-clonic convulsions 3, 4
Timing of Eclamptic Seizures
- 44% occur postnatally 4
- 38% occur antepartum 4
- 18% occur intrapartum 4
- Eclampsia is most common at term (≥37 weeks' gestation) 5
Screening and Assessment Protocol
Initial Risk Assessment (Before 20 Weeks)
Identify women with any of the following predisposing factors 1:
- First pregnancy (nulliparity) - RR 2.91 1, 5
- Previous pre-eclampsia - RR 7.19 1, 5
- ≥10 years since last baby 1
- Age ≥40 years - RR 1.68-1.96 1, 5
- Body mass index ≥35 - RR 1.55 1, 5
- Family history of pre-eclampsia (mother or sister) - RR 2.90 1, 5
- Booking diastolic blood pressure ≥80 mmHg 1
- Proteinuria at booking (≥+ on more than one occasion or ≥300 mg/24h) 1
- Multiple pregnancy - RR 2.93 1, 5
- Pre-existing diabetes - RR 3.56 1, 5
- Pre-existing hypertension or renal disease 1
- Presence of antiphospholipid antibodies - RR 9.72 1, 5
Monitoring After 20 Weeks
At every antenatal assessment, screen for the following signs and symptoms 1, 2:
- New hypertension (BP ≥140/90 mmHg) 1
- New proteinuria (≥+ on dipstick) 1
- Headache or visual disturbances 1
- Epigastric pain or vomiting 1
- Reduced fetal movements or small for gestational age infant 1
Monitoring Frequency
- Women with one risk factor: assess at least every 3 weeks before 32 weeks, then every 2 weeks until delivery 1, 5
- Women with no risk factors: follow standard antenatal protocols but educate about symptoms 1, 5
- Pre-eclampsia can progress to life-threatening status within approximately 2 weeks of diagnosis 1, 5, 2
Laboratory Evaluation
When pre-eclampsia is suspected, obtain 2:
- Complete blood count (assess for thrombocytopenia) 2
- Liver enzymes (AST, ALT) 2
- Serum creatinine and electrolytes 2
- Uric acid 2
- Urinalysis with protein quantification 2
Biomarker for Risk Stratification
- sFlt-1/PlGF ratio ≤38 can exclude development of pre-eclampsia in the following week when clinically suspected 2
Severity Classification
Pre-eclampsia with severe features includes 2, 3:
- Severe hypertension (≥160/110 mmHg) despite treatment with multiple antihypertensives 2
- Progressive thrombocytopenia (<100,000/μL) 2, 3
- Progressive abnormal renal function tests 2
- Progressive abnormal liver enzyme tests 2
- Pulmonary edema 2, 3
- Neurological complications (persistent headache, visual disturbances) 2, 3
- HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) 3
- Non-reassuring fetal status 2
Referral Thresholds from Community Settings
New Hypertension Without Proteinuria
- Diastolic BP ≥90 and <100 mmHg: refer for hospital assessment within 48 hours 1, 2
- Diastolic BP ≥90 and <100 mmHg WITH any symptoms: refer for same-day hospital assessment 1
- Diastolic BP ≥100 mmHg OR systolic BP ≥160 mmHg: refer for same-day hospital assessment 2
New Hypertension With Proteinuria
- Diastolic BP ≥90 mmHg with proteinuria ≥+ on dipstick: refer for same-day hospital assessment 2
- Diastolic BP ≥110 mmHg OR systolic BP ≥170 mmHg with proteinuria: arrange immediate admission 2
Postpartum Pre-eclampsia Diagnosis
Postpartum pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) occurring 48 hours to 6 weeks after delivery with either proteinuria or maternal organ dysfunction 6
Postpartum Monitoring Protocol
- Measure blood pressure at least every 4 hours while awake for at least 3 days postpartum 6
- Perform urinalysis if hypertension detected 6
- Screen for symptoms: headache, visual disturbances, epigastric pain, nausea/vomiting 6
- Review all women with postpartum pre-eclampsia at 3 months to ensure normalization 6
Critical Pitfalls to Avoid
- Do not classify pre-eclampsia as "mild" versus "severe" clinically - all cases may rapidly progress to emergencies 5
- Blood pressure alone is not reliable for risk stratification - serious organ dysfunction can develop at relatively mild hypertension levels 5
- Do not use serum uric acid or proteinuria levels as indications for delivery 2
- Do not rely on hyperreflexia - this is a nonspecific finding in healthy young women and no longer recommended as diagnostic criterion 2
- Absence of antenatal care is strongly associated with eclampsia and fetal death 5
- Women with no risk factors can still develop pre-eclampsia - maintain vigilance in all pregnancies 5